Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients.

Oncoimmunology · 2019 · PMC6422400 · PMID 30906658

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

borderline significantp = 0.053so close (0.05 < p ≤ 0.1)

For myeloid cells, only a high MFI PD-L1 on granulocytic MDSC value was significantly associated with poor PFS (log-rank test p = 0.04), and a high MFI PD-L1 on monocyte value was also associated with poor PFS but was borderline significant (log-rank test p = 0.053).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.